<DOC>
	<DOCNO>NCT02689934</DOCNO>
	<brief_summary>A randomized , double-blind , placebo-controlled , parallel study evaluate efficacy red yeast rice base nutraceutical ( monacolin K 10 mg/dose ) plus probiotic ( Bifidobacterium longum BB536 ® ) , versus placebo , patient moderate hypercholesterolemia , term improvement lipid profile cardiovascular risk .</brief_summary>
	<brief_title>Efficacy Red Yeast Rice Based Nutraceutical Plus Probiotic Patients With Moderate Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Red yeast rice</mesh_term>
	<mesh_term>Lovastatin</mesh_term>
	<mesh_term>L 647318</mesh_term>
	<mesh_term>Dihydromevinolin</mesh_term>
	<criteria>18 ≤ men woman ≤ 70 men female . Female must postmenopausal surgically sterile 130 mg/dl ≤ LDLC ≤ 200 mg/dl patient primary cardiovascular prevention pregnancy lactate patient chronic disease patient serious hepatic disease patient serious renal disease patient thyroid disease diabetes mellitus glycemia &gt; 126 mg/dl uncontrolled severe hypertension obesity ( BMI &gt; 30 ) smoking status drug nutraceutical interfere experimental treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>hypercholesterolemia</keyword>
	<keyword>bifidobacterium longum BB536</keyword>
	<keyword>red yeast rice</keyword>
	<keyword>monacolin K</keyword>
	<keyword>lactoflorene colesterolo</keyword>
</DOC>